Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

June 13, 2023

Study Completion Date

September 5, 2023

Conditions
Atopic Dermatitis
Interventions
DRUG

Placebo Comparator

Sterile solution for subcutaneous injection

BIOLOGICAL

ASLAN004

Sterile solution for subcutaneous injection

BIOLOGICAL

ASLAN004

Sterile solution for subcutaneous injection

BIOLOGICAL

ASLAN004

Sterile solution for subcutaneous injection

BIOLOGICAL

ASLAN004

Sterile solution for subcutaneous injection

Trial Locations (83)

2010

Holdsworth House Medical Practice, Sydney

2217

Premier Specialist, Kogarah

3053

Skin Health Institute, Carlton

3128

Eastern Clinical Research, Box Hill

3204

Clinical Trials NZ, Hamilton

4102

Veracity Clinical Research, Woolloongabba

6160

Fremantle Dermatology, Fremantle

10012

Bobby Buka MD, PC, New York

10075

ASLAN Investigative Site, New York

11415

Forest Hills Dermatology Group, Kew Gardens

29407

Clinical Research Center of the Carolinas, Charleston

30033

ASLAN Investigative Site, Krakow

31011

ASLAN Investigative Site, Krakow

31217

Skin Care Physicians of Georgia, Macon

31904

ASLAN Investigative Site, Columbus

32080

ASLAN Investigative Site, Saint Augustine

33016

Aby's New Generation Research, Inc., Hialeah

33021

ASLAN Investigative Site, Hollywood

33100

ASLAN Investigative Site, Tarnów

33134

Driven Research, LLC, Coral Gables

33162

ASLAN Investigative Site, North Miami Beach

33173

Skin Research of South Florida, Miami

33176

ASLAN Investigative Site, Miami

33436

Encore Medical Research of Boynton Beach, Boynton Beach

33486

Skin Care Research, LLC, Boca Raton

33607

ASLAN Investigative Site, Tampa

33613

ForCare Clinical Research, Tampa

35209

ASLAN Investigative Site, Birmingham

35244

ASLAN Investigative Site, Birmingham

37215

ASLAN Investigative Site, Nashville

40217

ASLAN Investigative Site, Louisville

40611

ASLAN Investigative Site, Katowice

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48103

ASLAN Investigative Site, Ann Arbor

50566

ASLAN Investigative Site, Wroclaw

57702

ASLAN Investigative Sites, Rapid City

70808

ASLAN Investigative Site, Baton Rouge

72205

ASLAN Investigative Site, Little Rock

75230

Dermatology Treatment and Research Center, Dallas

75231

Modern Research Associates, Dallas

75246

Menter Dermatology Research Institute, Dallas

77004

Center for Clinical Studies LTD, LLP, Houston

78209

ASLAN Investigative Site, San Antonio

83642

ASLAN Investigative Site, Meridian

84095

ASLAN Investigative Site, South Jordan

85231

ASLAN Investigative Site, Bydgoszcz

89148

ASLAN Investigative Site, Las Vegas

90033

ASLAN Investigative Site, Los Angeles

90057

ASLAN Investigative Site, Los Angeles

90404

Clinical Science Institute, Santa Monica

90436

ASLAN Investigative Site, Lodz

91436

Tooraj Raoof, MD, Encino

92103

MedDerm Associates, San Diego

92708

ASLAN Investigative Site, Fountain Valley

94538

Center for Dermatology Clinical Research, Inc., Fremont

97210

Oregon Dermatology and Research Center, Portland

97239

Oregon Health & Science University, Portland

97504

ASLAN Investigative Site, Medford

110060

Sir Ganga Ram Hospital, New Delhi

119260

ASLAN Investigative Site, Singapore

169608

ASLAN Investigative Site, Singapore

229899

KK Women's and Children's Hospital, Singapore

308205

National Skin Centre, Singapore

380016

B. J. Medical College and Civic Hospital, Asarwa

395002

Nirmal Hospital Pvt Ltd., Surat

400706

D Y Patil Hospital, Navi Mumbai

411057

Lifepoint Multispeciality Hospital, Pune

440019

NKP Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur

530002

King George Hospital, Visakhapatnam

700073

Calcutta School of Tropical Medicine, Kolkata

01915

Allcutis Research LLC, Beverly

02169

ASLAN Investigative Site, Quincy

02919

Clinical Partners, LLC, Johnston

R3M 3Z4

Wiseman Dermatology Research, Inc., Winnipeg

N6H 5L5

DermEffects, London

L3P 1X3

ASLAN Investigative Site, Markham

M3B 3S6

Gordon Sussman Clinical Research Inc., North York

K9J 5K2

Skin Centre for Dermatology, Peterborough

1W4R4

Centre de Recherche Saint-Louis (Quebec), Québec

G1V 4X7

Centre de Recherche dermatologique du Quebec Metropolitain, Québec

00000

ASLAN Investigative Site, Santo Domingo

01817

ASLAN Investigative Site, Warsaw

02953

ASLAN Investigative Site, Warsaw

Sponsors
All Listed Sponsors
lead

ASLAN Pharmaceuticals

OTHER

NCT05158023 - Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter